Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

WVE

+ Watchlist+ Portfolio

Wave Life Sciences Ltd.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.84
52-Week Range
$2.75 – $21.73
Market Cap
$546.32M
P/E (TTM)
—
EPS (TTM)
-1.07
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.36
PEG Ratio
—
Return on Equity
-78.80%
Return on Assets
-37.97%
Gross Margin
-189.60%
Operating Margin
-320.94%
Profit Margin
-296.86%
Current Ratio
8.38
Debt/Equity
0.11
Total Debt
$43.27M
Free Cash Flow
$-132.66M
Revenue Growth
73.00%
Earnings Growth
—
Enterprise Value
$158.85M

Market Snapshot

About

Wave Life Sciences Ltd. is a clinical-stage genetic medicines company. The company develops stereopure oligonucleotide therapies targeting genetic diseases affecting the central nervous system, liver, and other organs.